Cargando…
Successful Use of Immunotherapy in a Patient with Metastatic Squamous Cell Lung Cancer and Underlying Autoimmune Disease
The immune system removes abnormal and cancerous cells by way of T-cell detection at immune checkpoints. Cancerous cells, due to their expression of proteins such as T-cell inactivating programmed death-ligand 1 (PD-L1), may evade the immune system resulting in replication and ultimately metastases....
Autores principales: | Zakharian, Lusine, Lee, Lauren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310659/ https://www.ncbi.nlm.nih.gov/pubmed/34336422 http://dx.doi.org/10.7759/cureus.15918 |
Ejemplares similares
-
Combined Immunotherapy in Metastatic Melanoma with Unknown Primary
por: Khan, Yasir, et al.
Publicado: (2019) -
Liquefied Lung Cancer: An Uncommon Form of Squamous Cell Carcinoma of the Lung
por: Javed, Nismat, et al.
Publicado: (2023) -
A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy
por: Fadel, Celine A, et al.
Publicado: (2022) -
A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy
por: Atiq, Saad, et al.
Publicado: (2021) -
Metastatic Lung Cancer to the Distal Finger Presenting as Osteomyelitis
por: Garabet Diramerian, Liza, et al.
Publicado: (2020)